HomeTNYA • NASDAQ
Tenaya Therapeutics Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.65M | -21.61% |
Net income | -23.84M | 20.37% |
Net profit margin | — | — |
Earnings per share | -0.28 | 30.00% |
EBITDA | -22.56M | 22.90% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.45M | -41.28% |
Total assets | 119.94M | -29.66% |
Total liabilities | 27.09M | -12.88% |
Total equity | 92.85M | — |
Shares outstanding | 87.58M | — |
Price to book | 0.45 | — |
Return on assets | -47.31% | — |
Return on capital | -52.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.84M | 20.37% |
Cash from operations | -18.39M | 16.13% |
Cash from investing | 14.10M | 194.53% |
Cash from financing | 377.00K | 1.62% |
Net change in cash | -3.91M | 89.28% |
Free cash flow | -9.80M | 27.90% |
Previous close
$0.48
Day range
$0.47 - $0.52
Year range
$0.39 - $4.96
Market cap
42.99M USD
Avg Volume
4.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
97
